Comprehensive study of neoadjuvant targeted therapy for resectable non-small cell lung cancer

BACKGROUND: Approximately 30–70% percent of patients with non-small cell lung cancer (NSCLC) still relapse after receiving complete resection and even suffer distant metastasis. Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have gradually replaced chemotherapy to become the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Transl Med
Autors principals: Bao, Yi, Gu, Chang, Xie, Huikang, Zhao, Shengnan, Xie, Dong, Chen, Chang, Jiang, Gening, Dai, Chenyang, Zhu, Yuming
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8039639/
https://ncbi.nlm.nih.gov/pubmed/33850890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-21-1134
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars